22 min listen
Front-Line Treatment of Chronic Lymphocytic Leukemia
Front-Line Treatment of Chronic Lymphocytic Leukemia
ratings:
Length:
54 minutes
Released:
Oct 13, 2020
Format:
Podcast episode
Description
For this special edition of Oncology Today, I met with Dr John Pagel from the Swedish Cancer Institute in Seattle to discuss recently published and emerging research in the front-line treatment of chronic lymphocytic leukemia.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayFrontLineCLL20/).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayFrontLineCLL20/).
Released:
Oct 13, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love